Business
PepGen to Participate in the Leerink Global Healthcare Conference
BOSTON--(BUSINESS WIRE)-- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with
About this update from Pepgen Inc.
BOSTON --(BUSINESS WIRE)-- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that James McArthur , PhD, President and CEO of PepGen , will participate in a fireside chat at the Leerink Global Healthcare Conference on Tuesday, March 10, 2026 at 3:00 p.m. ET in Miami, Florida . A webcast of the event will be available on the "Events & Presentations" page within the Investors section of the PepGen website at https://investors.pepgen.com/ . A replay of the webcast will be available on the PepGen website for 90 days following the presentation date. About PepGen PepGen is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide (EDO) platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, PepGen is generating a pipeline of oligonucleotide therapeutic candidates that are designed to target the root cause of serious diseases. For more information, please visit www.pepgen.com . Follow PepGen on LinkedIn and X . View source version on businesswire.com : https://www.businesswire.com/news/home/20260303196517/en/ Investor Contact Laurence Watts New Street Investor Relations [email protected] Media Contact Julia Deutsch Lyra Strategic Advisory [email protected] Source: PepGen Inc.